Hospira is buying an FDA-approved API manufacturing facility and associated R&D facility from Orchid Chemicals and Pharmaceuticals, for about $200 million.
Projects will add capacity to produce plasma intermediates in Kankakee, IL, site, and albumin in Melbourne
Testa Center focuses on advancing manufacturing capabilities and the commercialization of new technologies in life sciences, aligning with Sweden's goals of strengthening its capacity for innovation and thus its economic competitiveness.
Cardiovascular disease is alleviated by an engineered protein, a stable version of a chaperone protein found in good cholesterol, that helps suppress inflammation, lower blood pressure, and reverse tissue damage in mouse models
After Type A meeting with FDA, company ends rights agreement with Ipsen, concludes no partners "in any region of the world" can be found for MCNA short-term
Study in JCI observed that TGF-beta-1 increased expression of the protein, which decreased p53 activity.
Sartorius' Flexsafe family allows single-use bioprocessing over the entire range of drug manufacture, from process development to production.
Firm is developing VLP-based vaccines. Vivalis has granted Novavax the right to use its EB66® cell line for the production of VLP-based vaccines against several new potential viruses. The EB66 cell line is derived from...
Companies obtain sublicenses to patents in the fields of non-invasive sensing and automated ascepti solution transfer.
EMD Millipore and Samsung BioLogics signed a Memorandum of Understanding (MOU) for a strategic alliance to encompass a long-term supply agreement.
Please wait while you are redirected to the right page...